Griffin, Donald R.
Archang, Maani M.
Kuan, Chen-Hsiang
Weaver, Westbrook M.
Weinstein, Jason S.
Feng, An Chieh
Ruccia, Amber
Sideris, Elias
Ragkousis, Vasileios
Koh, Jaekyung
Plikus, Maksim V. http://orcid.org/0000-0002-8845-2559
Di Carlo, Dino
Segura, Tatiana http://orcid.org/0000-0003-1569-8686
Scumpia, Philip O. http://orcid.org/0000-0002-2563-2042
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01NS094599, R01HL110592, K08AR066545)
Article History
Received: 5 March 2019
Accepted: 25 September 2020
First Online: 9 November 2020
Competing interests
: D.R.G., W.M.W., D.D.C., T.S., and P.O.S. have a financial interest in Tempo Therapeutics, which aims to commercialize MAP technology.